Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment

NCT02859103 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Depression
Anhedonia

Interventions

DRUG: Desvenlafaxine

Sponsor

Unity Health Toronto